Bausch Health Companies Inc (BHC)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 9.030 |
|---|---|
| 52-week range | 6.100 – 11.080 |
| Return, 1 month / 3 months | +12.3% / +43.8% |
| Return, 1 year / 3 years | +1.1% / −6.3% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 54.2% |
| Worst drawdown (1 year) | -42.9% |
| Average daily value traded | 5.95M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bausch Health Companies is a pharmaceutical and medical device company based in Canada. It develops and sells prescription medicines and over-the-counter products, with a focus on eye health through its Bausch and Lomb business, which offers contact lenses, lens care products and surgical equipment. The company also provides treatments in areas such as gastroenterology, dermatology and neurology, serving patients, doctors and healthcare providers in markets around the world.
Bausch Health Companies Inc trades under the code BHC on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bausch Health Companies Inc (BHC) trades on the Toronto Exchange in Canada. It last closed at CAD 9.030 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 299 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.1% and over the last three months it rose 43.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.1% | ||
| From 52-week high | -17.5% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 43.8% | ||
| 6-month return | 19.0% | ||
| 12-month return, skipping the last month | -10.0% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 54.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.9% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 5.95M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +12.3% |
| 3 months | +43.8% |
| 6 months | +19.0% |
| 1 year | +1.1% |
| 3 years | −6.3% |
| 5 years | −74.6% |
Signals
| 50-day / 200-day average | 8.659 / 7.913 |
|---|---|
| Golden / death cross (60 days) | Golden, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.319 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.